Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Complementary Medicine Use Linked to Healthcare Cost Savings, Finds Frost & Sullivan 2014-10-15 07:26
Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel 2014-10-15 04:44
Abbott Celebrates the Power of Health and Achievement as First-Ever Title Sponsor of World Marathon Majors 2014-10-10 23:06
Manuela Leone MD Joins Aptuit Leadership Team As Executive V.P. And Verona General Manager 2014-10-10 01:30
In Vitro Diagnostics Players Go Global, says Frost & Sullivan, as US and Europe Markets Slow Down 2014-10-10 00:25
BioXcel to Present 'The World Data Impact on Pharma R&D Strategy' at Phacilitate Big Data Leaders' Forum 2014 in Washington D.C. 2014-10-08 17:00
1st and largest multi-country study in Asia reveals patients require better specialist care and pharmacotherapy to treat the growing burden of pain 2014-10-06 10:55
Norgine Enrols First Patient in the Phase III NOCT Study to Evaluate Bowel Cleansing Efficacy of NER1006, a Novel, Low Volume Bowel Preparation, vs. Trisulfate 2014-10-03 14:00
Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA for its Robust Pipeline of Novel Therapeutic Proteins 2014-09-29 23:59
Boehringer Ingelheim's afatinib Achieves Primary Endpoint in Global Phase III Study in Recurrent/Metastatic Head and Neck Squamous Cell Cancer 2014-09-27 15:00
Daiichi Sankyo Receives Approval for Additional Indications of LIXIANA® (edoxaban) in Japan 2014-09-26 19:57
World Heart Federation Announces a Donation from Bristol-Myers Squibb and Pfizer for a Program to Help Improve Experiences for People with Atrial Fibrillation (AF) 2014-09-25 02:46
TauRx Therapeutics Achieves Enrolment Target for Second Phase III Clinical Trial of LMTX™ in Alzheimer's Disease 2014-09-22 08:00
New Xultophy® (IDegLira) Data Show Rapid and Predictable Glycaemic Improvements in People with Type 2 Diabetes 2014-09-19 21:33
Merck Serono Awards Grant for Growth Innovation (GGI) for the First Time 2014-09-19 15:30
Merck Strengthens Executive Board 2014-09-19 01:56
Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine 2014-09-17 02:10
First European Patients Enrolled in QT Vascular's ENDURE Trial 2014-09-16 01:46
Alchem International Commits to Tropane Alkaloid APIs and Extends Production and Regulatory Support to Resolve Supply Gap 2014-09-15 09:00
Merck Discontinues Clinical Development Program of Tecemotide as a Monotherapy in Stage III Non-Small Cell Lung Cancer 2014-09-12 22:47
1 380 381 382 383 384 385